MCRB Matthew R. Henn sold Seres Therapeutics, Inc. shares — SEC Form 4SELLSeres Therapeutics, Inc.

Matthew R. Henn, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 77 shares at $7.28 ($561) on 2025-05-16, disclosed to the SEC on 2025-05-19.

SEC EDGAR Filing

0000950170-25-074323

View on SEC EDGAR

Trade context

Scheduled sale ($561) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest50/100

Nothing distinguishes this filing.

Exercise & SellOpportunistic Sell

Filing Info

Filed2025-05-19

Traded2025-05-16

Accession0000950170-25-074323

Sourcesec_form345

Insider

NameMatthew R. Henn

TitleSee Remarks

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
MCRB	SELL	2026-08-18	$369	—	Filing →
MCRB	SELL	2026-05-19	$580	—

Get alerted the next time MCRB files

Every new MCRB Form 4, within minutes of it hitting EDGAR. 7-day free trial, no credit card required.

Follow MCRB

MCRB Matthew R. Henn sold Seres Therapeutics, Inc. shares — SEC Form 4SELLSeres Therapeutics, Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes